The features of choosing a drug for the initial therapy of iron-deficiency anemia in children

DOI: https://doi.org/10.29296/25877305-2019-05-04
Download full text PDF
Issue: 
5
Year: 
2019

V. Lebedev; Professor V. Demikhov, MD; E. Demikhova; Yu. Abalenikhina, Candidate of Biological Sciences; A. Dmitriev, MD Ryazan State Medical University

The paper evaluates and compares the efficacy and toxicity of drugs based on iron (III)- hydroxide polymaltose complex and iron (II) sulfate given in standard doses for the treatment of iron-deficiency anemia in children.
Keywords: 
hematology
iron-deficiency anemia
treatment
iron sulfate
iron-hydroxide polymaltose complex
efficacy
safety
undesirable events
children
oxidative stress
protein oxidative modification

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Pasricha S., Black J., Muthayya S. et al. Determinants of Anemia Among Young Children in Rural India // Pediatrics. – 2010; 126 (1): e140–e149.
  2. Chang S., Wang L., Wang Y. et al. Iron-Deficiency Anemia in Infancy and Social Emotional Development in Preschool-Aged Chinese Children // Pediatrics. – 2011; 127 (4): e927–e933.
  3. Foote E., Sullivan K., Laird J. et al. Determinants of anemia among preschool children in rural, western Kenya // Am. J. Trop. Med. Hyg. – 2013; 88 (4): 757–64.
  4. Kuznik B.I., V.G. Sturov N.Ju. Levshin i dr. Gemorragicheskie i tromboticheskie zabolevanija i sindromy u detej i podrostkov: Patogenez, klinika, diagnostika, terapija i profilaktika. 2-e izd., pererab. i dop. / Novosibirsk: Nauka, 2018; 524 s. [Kuznik B.I., V.G. Sturov N.Yu. Levshin et al. Gemorragicheskie i tromboticheskie zabolevaniya i sindromy u detei i podrostkov: Patogenez, klinika, diagnostika, terapiya i profilaktika. 2-e izd., pererab. i dop. / Novosibirsk: Nauka, 2018; 524 s. (in Russ.)].
  5. Andreeva T.A., Zorenko V.Ju., Davydkin I.L. i dr. Effektivnost' i bezopasnost' preparata Oktofaktor v lechenii bol'nyh s tjazheloj i srednetjazheloj formoj gemofilii A (rezul'taty 2-j chasti klinicheskogo issledovanija II i III fazy) // Vopr. gematol. onkol. i immunopatol. v pediat. – 2013; 12 (4): 31–7 [Andreeva T.A., Zorenko V.Yu., Davydkin I.L. et al. Efficiency and safety of Octofactor in the treatment of patients with severe and moderate hemophilia A: Results of part 2 of phase II–III clinical trial // Vopr. gematol. onkol. i immunopatol. v pediat. – 2013; 12 (4): 31–7 (in Russ.)].
  6. Zaharova I.N., Machneva E.B. Korrektsija defitsita zheleza: istoricheskie i sovremennye aspekty // Voprosy prakticheskoj pediatrii. – 2014; 9 (4): 2–7 [Zakharova I.N., Machneva E.B. Correction of iron deficiency: background and current aspects // Voprosy prakticheskoi pediatrii. – 2014; 9 (4): 2–7 (in Russ.)].
  7. Gorodetskij V.V., Goduljan O.V. Zhelezodefitsitnye sostojanija i zhelezodefitsitnaja anemija: lechenie i diagnostika / M.: Medpraktika-M, 2008; 1–27 [Gorodetskii V.V., Godulyan O.V. Zhelezodefitsitnye sostoyaniya i zhelezodefitsitnaya anemiya: lechenie i diagnostika / M.: Medpraktika-M, 2008; 1–27 (in Russ.)].
  8. Powers J., Buchanan G., Adix L. et al. Effect of Low-Dose Ferrous Sulfate vs Iron Polysaccharide Complex on Hemoglobin Concentration in Young Children With Nutritional Iron-Deficiency Anemia. A Randomized Clinical Trial // JAMA. – 2017; 317 (22): 2297–304.
  9. Haliotis F., Papanastasiou D. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children // Int. J. Clin. Pharmacol. Ther. – 1998; 36 (6): 320–5.
  10. Oral iron for Anemia: a review of the clinical effectiveness, cost-effectiveness and guidelines. Rapid response report. Summary with critical appraisal. Canadian Agency for Drugs and Technologies in Health. Available at: https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0084957/pdf/PubMedHealth_PMH0084957.pdf
  11. Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview // Scientific World J. – 2012; 2012: 846824.
  12. Machneva E.B. Optimizatsija diagnostiki i kontrolja effektivnosti terapii zhelezodefitsitnyh sostojanij u detej. Avtoref. dis. ... kand. med. nauk. M., 2016; 25 s. [Machneva E.B. Optimizatsiya diagnostiki i kontrolya effektivnosti terapii zhelezodefitsitnykh sostoyanii u detei. Avtoref. dis. ... kand. med. nauk. M., 2016; 25 s. (in Russ.)].
  13. Jaber L., Rigler S., Taya A. et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy // J. Pediatr. Hematol. Oncol. – 2010; 32 (8): 585–8.
  14. Yasa B., Agaoglu L., Unuvar E. Efficacy, tolerability, and acceptability of iron hydroxide polymaltose complex versus ferrous sulfate: a randomized trial in pediatric patients with iron deficiency anemia // Int. J. Pediatr. – 2011; 2011: Article ID 524520. http://dx.doi.org/10.1155/2011/524520.
  15. Kaneto H., Katakami N., Matsuhisa M. et al. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis // Mediators Inflamm. – 2010; 2010: 453892. DOI: 10.1155/2010/453892.
  16. Rodrigo R., González J., Paoletto F. The role of oxidative stress in the pathophysiology of hypertension // Hypertens Res. – 2011; 34 (4): 431–40. DOI: 10.1038/hr.2010.264.
  17. Darvesh A., Carroll R., Bishayee A. et al. Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents // Expert Rev. Neurother. – 2010; 10 (5): 729–45. DOI: 10.1586/ern.10.42.
  18. Giacco F., Brownlee M. Oxidative stress and diabetic complications // Circ. Res. – 2010; 107 (9): 1058–70.
  19. Kirilenko E.A., Onopko V.F. Okislitel'nyj stress i muzhskaja fertil'nost': sovremennyj vzgljad na problemu // Acta Biomedica Scientifica. – 2017; 2 (2): 102–8 [Kirilenko E.A., Onopko V.F. Oxidative stress and male fertility: modern view on the problem // Acta Biomedica Scientifica. – 2017; 2 (2): 102–8 (in Russ.)].
  20. Kennedy G., Spence V., McLaren M. et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms // Free Radical Biology and Medicine. – 2005; 39 (5): 584–9.
  21. Lebedev V.V., Demihov V.G., Fomina M.A. i dr. Metod kompleksnoj otsenki produktov okislitel'noj modifikatsii belkov dlja opredelenija bezopasnosti dvuh- i trehvalentnyh peroral'nyh preparatov zheleza i ih effektivnosti v lechenii zhelezodefitsitnoj anemii u detej // Pediatrija. – 2018; 97 (5): 47–53 [Lebedev V.V., Demikhov V.G., Fomina M.A. et al. A method for the complex evaluation of proteins oxidative modification products for determination of bivalent and trivalent oral iron preparations and their efficacy in iron deficiency anemia treatment in children // Pediatria. – 2018; 97 (5): 47–53 (in Russ.)].
  22. Mamaev A.N., Kudlaj D.A. Vizualizatsija dannyh v prezentatsijah, otchetah i issledovanijah / M.: Prakticheskaja meditsina, 2011; 39 s. [Mamaev A.N., Kudlai D.A. Vizualizatsiya dannykh v prezentatsiyakh, otchetakh i issledovaniyakh / M.: Prakticheskaya meditsina, 2011; 39 s. (in Russ.)].
  23. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniju zhelezodefitsitnoj anemii. Natsional'noe obschestvo detskih gematologov, onkologov / M., 2014 [Federal’nye klinicheskie rekomendatsii po diagnostiki i lecheniyu zhelezodefitsitnoi anemii, Natsional’noe obshchestvo detskikh gematologov, onkologov / M., 2014 (in Russ.)]. Rezhim dostupa / Available at: http://nodgo.org/sites/default/files/FKR%20po%20diagnostike%20i%20lecheniju%20zhelezodefitsitnoj%20anemii.pdf
  24. Fomina M.A., Abalenihina Ju.V., Fomina N.V. i dr. Sposob kompleksnoj otsenki soderzhanija produktov okislitel'noj modifikatsii belkov v tkanjah i biologicheskih zhidkostjah: metodicheskie rekomendatsii / Rjazan': RIORjazGMU, 2014; s. 36–9 [Fomina M.A., Abalenikhina Yu.V., Fomina N.V. et al. Sposob kompleksnoi otsenki soderzhaniya produktov okislitel’noi modifikatsii belkov v tkanyakh i biologicheskikh zhidkostyakh: metodicheskie rekomendatsii / Ryazan’: RIORyazGMU, 2014; s. 36–9 (in Russ.)].
  25. Dubinina E.E., Burmistrov S.O., Hodov D.A. i dr. Okislitel'naja modifikatsija belkov syvorotki krovi cheloveka, metod ee opredelenija // Voprosy meditsinskoj himii. – 1995; 41 (1): 24–6 [Dubinina E.E., Burmistrov S.O., Khodov D.A. i dr. Okislitel’naya modifikatsiya belkov syvorotki krovi cheloveka, metod ee opredeleniya // Voprosy meditsinskoi khimii. – 1995; 41 (1): 24–6 (in Russ.)].